Neutralizing and nonneutralizing monoclonal antibodies to the peplomer glycoprotein and nucleocapsid protein of a mouse hepatitis virus (MHV), MHV-NuU, protected mice against lethal MHV-2 challenge. Histopathologically, livers of mice receiving protective antibodies showed some focal necrotic lesions with remarkable cellular infitration instead of fulminant hepatitis caused by MHV-2.
Mouse hepatitis virus (MHV) is a member of the coronavirus group producing both acute and chronic diseases in various species of animals (15, 17, 25) . Most MHV strains have been shown to have the nucleocapsid protein (NP) and the minor (El) and major (E2) envelope glycoproteins (18, 19) . El is probably of the viral matrix, whereas E2 forms the peplomers that have important roles in attachment to host cells (18, 19) .
We described previously the production of monoclonal antibodies (MAbs) to low-virulence MHV-NuU, an isolate from a wasted nude mouse (7) , and their specificity for viral polypeptides (10) . Those MAbs were shown to be crossreactive in vitro with other strains of MHV including the highly hepatitogenic strain MHV-2 (6, 11, 12) . This paper describes protective effects of MAbs against E2 as well as NP of MHV-NuU in highly virulent MHV-2 infection in mice.
VN activity of MAbs and passive mouse protection. Ascitic fluids containing the MAbs used in this study were prepared as described previously (10) . They were examined for virusment (1:25) and anti-mouse immunoglobulin G (IgG) rabbit IgG (1:100) (Cooper Biomedical, Inc., West Chester, Pa.). MAbs 23-2:C2 and 14-1:C7 (Table 1) , both recognizing E2, showed VN activity against MHV-2 as well as MHV-NuU. In contrast, no VN activity against MHV-2 was shown with three other MAbs, 7-2:A2 recognizing E2 and 10-1:D2 and 23-1:G8 both recognizing NP, as already reported for VN activity against MHV-NuU (10). The presence of guinea pig complement with or without anti-mouse IgG antiserum had no effect.
Five-week-old female BALB/c mice purchased from a commercial breeder (Charles River Japan, Atsugi, Japan) received intraperitoneal injections of 0.1 ml of ascitic fluid containing each MAb, and 24 h later they were challenged intravenously with 30 PFU of MHV-2, which killed infected mice within 6 days. Animals were observed for mortality for 10 days postchallenge. MAb titers were not reduced during at least 11 (24) showed that neutralizing MAb to E2 of MHV-JHM immunized animals against lethal MHV-JHM infection. In studies with other enveloped viruses, nonneutralizing MAbs directed against viral glycoprotein immunized mice against lethal infection (1, 8, 9, 14, 16) .
The MAb to MHV is assumed to bind with the surface of infected host cells, causing cytolysis as in the case of either antibody-dependent cellular cytotoxicity or cytotoxicity mediated by complement-dependent antibody as has been described for various virus infections (13) . Although there have been no reports of NP expression on MHV-infected cell surfaces, it might be proposed that anti-NP MAb 10-1:D2 recognizes some NP-related antigens appearing on the surfaces of MHV-2-infected cells, as in case of influenza A virus infection (22, 23, 26) , resulting in cytolysis. The severer inflammatory response in the presence of effective MAbs may be due to this type of cytolysis, whereas the inflammatory cells themselves might have an inhibitory effect on virus spreading.
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